SPR 2017 Interventional Radiology Session May 20, 2017 SAM References
|
|
- Joanna Ellis
- 5 years ago
- Views:
Transcription
1 Update on Interventional Oncology Matthew P. Lungren, MD, MPH SPR 2017 Interventional Radiology Session May 20, 2017 SAM s 1. What percentage of pediatric HCC occurs in children with chronic liver disease? A. less than 10% B % C % D % Answer is C. Only 30 40% of pediatric HCC occurs in children with chronic liver diseases, with the most common causes being hereditary metabolic disorders such as tyrosinemia or alpha-1- antitripsin deficiency, chronic viral infections such as hepatitis C (HCV) or hepatitis B (HBV), and cholestatic disorders such as progressive familial intrahepatic cholestasis, congenital biliary atresia, or primary biliary cirrhosis. The remaining 60 70% of pediatric HCC develop within a normal liver with no recognized risk factors, often presenting in advanced stages with regional or distant metastases. s 1. Czauderna, P., Adult type vs. childhood hepatocellular carcinoma - Are they the same or different lesions? Biology, natural history, prognosis, and treatment. Medical and Pediatric Oncology, (5): p Which tumor response imaging guidelines are felt to be best for evaluating HCC after transarterial therapies such as TACE or Y90 and other anticancer drugs, such as molecular targeted therapies? A. RECIST B. Li-RADS C. mrecist D. WHO Answer is C. As acknowledged in the original RECIST publication, assessments based solely on changes in tumor size can be misleading when applied to other anticancer drugs, such as molecular targeted therapies, or other therapeutic interventions. In the case of hepatocellular carcinoma (HCC), recent studies have shown a poor correlation between the clinical benefit provided by new agents such as sorafenib or by loco-regional interventional therapies such as chemoembolization and conventional methods of response assessment. In 2006, a group of experts convened by the AASLD proposed adapting the concept of viable tumor endorsed by the EASL and the AASLD and to RECIST criteria for the determination of tumor response in HCC. These amendments are referred to as modified RECIST (mrecist).
2 s 1. Forner, A., et al., Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer, (3): p Which intervention has the best overall survival data for advanced non-metastatic (stage III) pediatric HCC? A. Surgical resection B. Systemic chemotherapy C. Liver Transplantation D. External Beam Radiotherapy Answer is C. Liver transplantation offers the advantage of treating any concurrent underlying liver disease while eradicating the tumor, and has demonstrated excellent long-term survival and a cure rate of approximately 75-80% 1. Cheng, E.Y. and R.W. Busuttil, Liver Transplantation for Pediatric Hepatoblastoma and Hepatocellular Carcinoma: Out of the Unknown. JAMA Surg, Update on MR Interventions in Children Joao Amaral, MD 4. Which is the MR guided non-invasive thermal therapy currently in clinical use? A. Cryoablation B. HIFU - High Focused Ultrasound Therapy C. Radiofrequency ablation D. LITT - Laser Interstitial Thermal Therapy Correct Answer: B Correct Answer is B. High-intensity focused ultrasound (HIFU) therapy, also known as focused ultrasound surgery (FUS), is a noninvasive technology that delivers ultrasound (US) waves via an extra- corporeal or endocavitary approach to specific targets within the human body. HIFU therapy results in targeted thermal ablation of tissue without injury to the surrounding structures. 1. High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy. Copelan A, Hartman J, Chehab M, Venkatesan AM. Semin Intervent Radiol Dec;32(4):
3 5. What is the best imaging method to identify the iceball created during cryoablation? A. Ultrasound B. CT C. MRI D. Cone beam CT Correct Answer is C. On conventional MRI sequences, frozen tissue appears as a signal void because of short transverse relaxation time, which creates high contrast between frozen and unfrozen tissue that is superior to that of CT or ultrasound. 1. Morrison PR, Silverman SG, Tuncali K, Tatli S. MRI-guided cryotherapy. J Magn Reson Imaging 2008; 27: The artifact caused by needles in MRI helps to identify these needles in the body. Which of the following does not interfere with needle artifact width in the MRI? A. Phase encoding direction B. Material (e.g. titanium, carbon fiber) C. Field strength D. Needle orientation to B(0) Correct Answer is A. Artifact widths depended on needle materials and needle orientation to B(0), with significant differences on tests. No significant influence on artifact character was found for changes in phase encoding direction and slice orientation. 1. In vitro assessment of needle artifacts with an interactive threedimensional MR fluoroscopy system. Thomas C, Springer F, Röthke M, Rempp H, Clasen S, Fritz J, Claussen CD, Pereira PL. J Vasc Interv Radiol Mar;21(3): Spinal Pain Procedures: Role of Nerve Root Blocks, Medial Branch Blocks, Epidural Steroid Injections, Cementoplasty, etc. Manraj Heran, MD 7. With respect to patients with disc herniation and associated spinal pain, which of the following is a true statement: A. The majority get better within 6-8 weeks B. Half will have symptoms beyond 3 months C. Surgery is usually indicated for those with pure sensory symptoms D. Conservative therapy typically does not work
4 Most correct answer is A. Option A is correct. The vast majority of patients (90%) will be better within 6-8 weeks. Option B is incorrect. Only a small proportion of patients will have symptoms beyond 3 months. Option C is incorrect. Surgical intervention is rarely necessary in the pediatric setting, especially in the acute/subacute phase. Pure sensory symptoms are not an indication for surgery. However, motor symptoms, such as root-compression related weakness, often are an indication for urgent surgical intervention. Option D is incorrect. Conservative therapy remains the mainstay of management, with appropriate restriction of activities, physical and chiropractic therapy, graded rehabilitation, and analgesic/anti-inflammatory medications, as needed. 8. Which of the following ARE NOT examples of percutaneous spinal pain management techniques which can be offered to pediatric patients: A. Medial branch block B. Cordotomy C. Epidural steroid injection D. Cementoplasty Correct Answer: B The incorrect answer is B. Option A is correct. Medial branch blocks are widely performed for facet-mediated pain, and are one of the most straightforward injection procedures to learn and perform. Option B is incorrect. Cordotomy is a percutaneous CT-guided procedure where a thermally (typically radiofrequency) induced lesion is created in the spinothalamic tract of the spinal cord. This is performed in the setting of intractable pain, most often in the palliative cancer setting, where the life expectancy of the patient is less than one year. As the performance of this procedure requires a still, cooperative patient who can answer questions appropriately during the procedure, its use in the pediatric setting would be exceedingly rare. Option C is correct. Epidural steroid injections are widely used for management of nonradicular/polyradicular back pain. Option D is correct. Although not typically performed in the pediatric setting, cementoplasty has a proven role in managing malignancy-based pain in the appendicular and axial skeleton in adults, and can, in selected settings, be considered an option in children.
5 9. With respect to steroids typically used in spinal pain procedures, which of the following is incorrect: A. No alterations in serum glucose are seen in the immediate post-procedure setting B. Particulate steroids should be avoided in cervical and thoracic procedures C. Duration of pharmacologic efficacy is typically three months D. Emotional lability and insomnia are rare side effects Option A is incorrect. Although the effects are dose-dependent, steroids typically used for spinal pain procedures are potent suppressors of insulin action. This is especially important to consider in patients with diabetes. The maximal serum glucose elevation typically occurs at 48 hours, and normalizes at approximately one week. Option B is correct. As a safety precaution, particulate steroids should be avoided where there is a chance for inadvertent vascular (ie, arterial) injection. Rare reports have been published of stroke and spinal cord infarction following cervical and thoracic injection procedures, with one possible mechanism being injection of particulate steroids into the vertebral arteries, or into radiculomedullary branches supplying the spinal cord (ex: artery of Adamkiewitz). Option C is correct. Although quite variable, the accepted average duration of pharmacologic efficacy is approximately 12 weeks. However, the primary causative etiology for the patient s spinal pain may resolve during that period (ex: resolution of acute disc herniation), giving the patient the impression of clinical efficacy well beyond that period. Option D is correct. Apart from systemic effects mediated through the hypothalamus-pituitaryadrenal axis, including suppression of insulin action as already discussed, other side effects may include: mood changes; alteration in sleep pattern; effects on menstruation. s for questions Image-Guided Spine Intervention. DS Fenton, LF Czervionke. Jacksonville, Florida: Saunders; Spinal Injection Procedures: Concepts, Controversies, and Complications MKS Heran, AD Smith, GM Legiehn Radiologic Clinics of North America (Guest Editor: Dr. PL Munk) May 2008: 46(3): Role of IR Trauma/Emergency IR Procedures Jared Green, MD and Stanley Kim, MD 10. What is the USA s leading cause of death in patients aged 1yr 14 yrs? A. Unintentional injury B. Homicide C. Congenital anomaly D. Malignant neoplasm 1. National Vital Statistics System 2014 data, National Center for Health Statistics, CDC.
6 11. How many people aged 0-19 yrs were shot and killed in Chicago in 2016? A. 15 B. 58 C. 155 D Chicago Tribune 12. What is the leading cause of upper gastrointestinal bleeding in children of North and South America? A. Varices B. Erosive esophagitis C. Peptic ulcer disease D. Vomiting induced hematemesis 1. Owensby S, Taylor K, Wilkins T. Diagnosis and management of upper gastrointestinal bleeding in children. J Am Board Fam Med 2015 Jan-Feb;28(1): Hematologist Aspect of Vascular Malformation: What We Need to Know from a Medical Aspect Kiersten W. Ricci, MD, FAAP 13. Which vascular anomaly is associated with Kasabach-Merritt phenomenon? A. Congenital hemangioma B. Infantile hemangioma C. Kaposiform hemangioendothelioma D. Venous malformation Occurring in approximately 70% of patients with kaposiform hemangioendothelioma and 10% of patients with tufted angioma, Kasabach-Merritt phenomenon (KMP) is a potentially lifethreatening coagulopathy that has a high risk of bleeding. KMP is characterized by platelet trapping, activation of the coagulation cascade, and secondary consumption of coagulation factors within the abnormal vasculature of the KHE/TA tumor, resulting in profound thrombocytopenia, hypofibrinoginemia, elevated D-dimer and fibrin degradation products, and prolonged prothrombin time (PT) and activated partial thromboplastin time (aptt). Coagulopathy may occur in rapidly involuting congenital hemangiomas and venous malformations but is distinctly different than KMP. s 1. Croteau SE, Liang MG, Kozakewich HP, et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 2013; 162:142
7 2. O'Rafferty C, O'Regan GM, Irvine AD, Smith OP. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol 2015; 171(1): Baselga E, Cordisco MR, Garzon M, et al. Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series. Br J Dermatol 2008; 158: Andreu-Barasoain M, Naz E, Díaz M, López-Estebaranz JL. Rapidly involuting congenital hemangioma associated with transient anemia and thrombocytopenia. Int J Dermatol 2013; 52: Hung JW, Leung MW, Liu CS, et al. Venous Malformation and Localized Intravascular Coagulopathy in Children. Eur J Pediatr Surg Apr 18. [Epub ahead of print] 14. Localized intravascular coagulopathy is defined by which of the following? A. Prolonged prothrombin time (PT) and low platelet count only B. Prolonged PT and low fibrinogen only C. Prolonged partial thromboplastic time (aptt) and elevated D-dimer D. Elevated D-dimer, low platelet count and/or low fibrinogen Correct Answer: D Localized intravascular coagulopathy (LIC) is characterized by elevated D-dimer, low fibrinogen, and/or mild thrombocytopenia. LIC may progress to disseminated intravascular coagulopathy following surgical procedures. LIC is not defined by PT and/or PTT measurements but both PT and aptt may be prolonged if the fibrinogen is low. 1. Available at: issva.org/classification 15. Localized intravascular coagulopathy is associated with what vascular anomaly? A. Venous malformations B. Kaposiform hemangioendothelioma C. Arteriovenous malformations D. Capillary malformations Localized intravascular coagulopathy occurs in slow [blood] flow malformations including venous, venous-lymphatic, capillary-venous and capillary-lymphatic-venous malformations. Kaposiform hemangioendothelioma is associated with Kasabach-Merritt phenomenon. 1. Adams, DM. Special considerations in vascular anomalies: hematologic management. Clin Plast Surg Jan;38(1):
8 Sirolimus for the Management of Vascular Anomalies Adrienne M. Hammill, MD, PhD 16. Sirolimus inhibits which step in the growth pathway shown below? A. PIK3CA B. AKT C. mtor D. VEGF Sirolimus, also known as rapamycin, is a specific and potent inhibitor of mtor (mammalian target of rapamycin) via mtor complex 1. The mtorc1 signaling cascade is activated by phosphorylated AKT and results mrna translation, ultimately leading to protein synthesis. Rapamycin was first discovered in 1975 in soil sample from Easter Island, also known as Rapa Nui, hence its name is derived. Rapamycin is a macrolide produced by Streptomyces hygroscopius. It has shown both antifungal as well as immuosuppressive properties. Rapamycin was first widely used as an immunosuppressant for solid-organ transplant. s 1. Pópulo, Helena; Lopes, José Manuel; Soares, Paula (2012). "The mtor Signalling Pathway in Human Cancer". International Journal of Molecular Sciences. 13 (12): PMID Tsang, Chi Kwan; Qi, Haiyan; Liu, Leroy F.; Zheng, X.F. Steven (2007). "Targeting mammalian target of rapamycin (mtor) for health and diseases". Drug Discovery Today. 12 (3 4): PMID Sirolimus has shown efficacy in the treatment of which of the following vascular malformations? A. Capillary Malformations B. Lymphatic Malformations C. Arteriovenous Malformations D. Lymphedema Correct Answer: B Sirolimus has been shown to be effective for lymphatic malformations, both microcystic and macrocystic, as well as in combined lesions including lymphaticovenous malformations and capillary lymphaticovenous malformations. In a recent Phase II study, patients with lymphatic malformations showed symptomatic improvement in quality of life, clinical status, and often size. In that same study, patients lymphedema and other conduction anomalies of the lymphatic system did not significantly benefit from sirolimus. More recently, sirolimus has been used for pure venous malformations, with improvement in pain and objective improvement in signs of localized intravascular coagulopathy, with lowering of D-dimers and normalization of platelets and fibrinogen.
9 s 1. Adams DM, Trenor CC, Hammill AM, et al. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Pediatrics. 2016;137(2):e doi: /peds Boscolo E, Limaye N, Huang L, et al. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest. 2015;125(9): doi: /jci Sirolimus should be held in which of the following situations? A. Poor wound healing after surgery B. Routine sclerotherapy C. Fever in an otherwise well-appearing child D. Administration of inactivated vaccines Sirolimus has been associated with delayed skin healing after minor trauma and poor wound healing after surgery. However, due to its positive effect on lymphatic malformations, it is no longer being held for long periods after surgery unless they are concerns about wound healing. Sirolimus should NOT be held for fever alone in otherwise well-appearing patients and does not need to held for administration of routine killed vaccines. Annual flu shots are strongly encouraged, although LIVE vaccines (including nasal FluMist) are contraindicated during sirolimus therapy due to immunosuppression, and should not be given for several months after discontinuation of sirolimus to allow the immune function to recover. Sirolimus does not need to be held for less invasive procedures such as sclerotherapy or other intravascular procedures. s 1. Schäffer M, Schier R, Napirei M, et al. Sirolimus impairs wound healing. Langenbecks Arch Surg May;392(3): Campistol JM, Cockwell P, Diekmann F, et al. Practical recommendations for the early use of m-tor inhibitors (sirolimus) in renal transplantation. Transplant International, 2009: 22: Johnson JL, Thomas PG, McGargill MA. Understanding the cellular impact of low dose rapamycin treatment. J. Immunol, 2016:196 (1 Supp)
Liver Cancer And Tumours
Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationStaging & Current treatment of HCC
Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt
More information3. Discussion. 2 Case Reports in Pediatrics
Case Reports in Pediatrics Volume 2015, Article ID 537530, 4 pages http://dx.doi.org/10.1155/2015/537530 Case Report Paravertebral and Retroperitoneal Vascular Tumour Presenting with Kasabach-Merritt Phenomenon
More informationJesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center
Liver Tumors Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center Differential Diagnosis Malignant Metastatic from non-hepatic primary Hepatocellular carcinoma Cholangiocarcinoma Biliary cystcarcinoma
More informationLiver Cancer: Diagnosis and Treatment Options
Liver Cancer: Diagnosis and Treatment Options Fred Poordad, MD Chief, Hepatology University Transplant Center Professor of Medicine UT Health, San Antonio VP, Academic and Clinical Affairs, Texas Liver
More informationUpdate on Vascular Tumors
Update on Vascular Tumors Deepti Gupta, MD Assistant Professor Department of Pediatrics and Division of Dermatology Seattle Children s Hospital University of Washington School of Medicine PHOTOGRAPHY &
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationHepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer
More informationIndex. C Cancer, Carcinoid syndrome, 413. D DCIS. See Ductal carcinoma in situ (DCIS) DEB-TACE. See Drug eluting beads-tace (DEB-TACE)
Index A Ablation, 179 199, 843 853 devices, 179, 199 liver tumors, 527 techniques, 516 Ablative radiation therapy, 456 Accelerated partial breast, 894, 896 898 Adaptive radiation therapy, 586, 598, 602
More informationHepatocellular Carcinoma. Markus Heim Basel
Hepatocellular Carcinoma Markus Heim Basel Outline 1. Epidemiology 2. Surveillance 3. (Diagnosis) 4. Staging 5. Treatment Epidemiology of HCC Worldwide, liver cancer is the sixth most common cancer (749
More informationTumor incidence varies significantly, depending on geographical location.
Hepatocellular carcinoma is the 5 th most common malignancy worldwide with male-to-female ratio 5:1 in Asia 2:1 in the United States Tumor incidence varies significantly, depending on geographical location.
More informationCorporate Medical Policy
Corporate Medical Policy Cryosurgical Ablation of Primary or Metastatic Liver Tumors File Name: Origination: Last CAP Review: Next CAP Review: Last Review: cryosurgical_ablation_of_primary_or_metastatic_liver_tumors
More informationChief Complain. Liver lesion found in routine health check 41 days ago
Chief Complain Liver lesion found in routine health check 41 days ago Present Illness On 2005-7-26 at 台北署立醫院 he underwent a health check for the first time. Abdominal US showed suspicious of a 6*5 cm hepatoma,
More informationLearning Objectives. After attending this presentation, participants will be able to:
Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation
More informationInterventional Radiology in Liver Cancer. Nakarin Inmutto MD
Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT
More informationThrombocytopenia and Chronic Liver Disease
Thrombocytopenia and Chronic Liver Disease Severe thrombocytopenia (platelet count
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationLiver Tumors. Prof. Dr. Ahmed El - Samongy
Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma
More informationHepatobiliary Malignancies Retrospective Study at Truman Medical Center
Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationUltrasound imaging of vascular anomalies: pearls and pitfalls
Ultrasound imaging of vascular anomalies: pearls and pitfalls Oscar Navarro, MD Dept. of Medical Imaging, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Declaration of
More informationBrain Tumors. What is a brain tumor?
Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain
More informationPediatric Liver Tumors and Transplantation. Northwest Regional Pediatric Live Disease Symposium, Seattle WA, April 12, 2008
Pediatric Liver Tumors and Transplantation Northwest Regional Pediatric Live Disease Symposium, Seattle WA, April 12, 2008 Liver transplantation for primary liver tumours in children WHEN? - patient selection
More informationThe Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page
The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page 1674-1679 Radioembolization in Treatment of Hepatocellular Carcinoma with Portal Vein Invasion Elsahhar Ahmed Hetta, Osama Mohamed
More informationHemangiomas and Other Vascular Tumors
facebook.com/cincykidsrad Hemangiomas and Other Vascular Tumors Disclosures No relevant financial disclosures Bernadette L. Koch, M.D. Departments of Radiology and Pediatrics Cincinnati Children s Hospital
More informationVascular Tumors in Children and Adults. Thuy Phung, MD, PhD Houston Methodist Hospital Texas Children s Hospital Baylor College of Medicine
Vascular Tumors in Children and Adults Thuy Phung, MD, PhD Houston Methodist Hospital Texas Children s Hospital Baylor College of Medicine What are these lesions? (Marcelo Hochman, MD) What are these lesions?
More informationSonography of soft-tissue vascular lesions
Sonography of soft-tissue vascular lesions Oscar M. Navarro Associate Professor, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Toronto, Canada Declaration of Disclosure
More informationHow to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung
How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung End points in research for solid cancers Overall survival (OS) The most ideal one, but requires long follow-up duration
More informationIS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS?
IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS? Dr. Sammy Saab David Geffen School of Medicine, Los Angeles, USA April 2018 DISCLAIMER Please note: The views
More informationPublished: Address correspondence to Vidal-Jove Joan:
Oncothermia Journal 7:111-114 (2013) Complete responses after hyperthermic ablation by ultrasound guided high intensity focused ultrasound (USgHIFU) plus cystemic chemotherapy (SC) for locally advanced
More informationLocoregional Treatments for HCC Applications in Transplant Candidates. Locoregional Treatments for HCC Applications in Transplant Candidates
Locoregional Treatments for HCC Applications in Transplant Candidates Matthew Casey, MD March 31, 2016 Locoregional Treatments for HCC Applications in Transplant Candidates *No disclosures *Off-label uses
More informationHepatocellular carcinoma
Hepatocellular carcinoma Mary Ann Y. Huang, M.D., M.S., FAASLD Transplant hepatologist Peak Gastroenterology Associates Porter Adventist Hospital Denver, Colorado Background - Worldwide Hepatocellular
More informationAdvances in percutaneous ablation for hepatocellular carcinoma
Advances in percutaneous ablation for hepatocellular carcinoma P. Nahon1,2,3 1 Hepatology, Jean Verdier Hospital, APHP, Bondy, France 2 Paris 13 university, Sorbonne Paris Cité, UFRSMBH, Bobigny, France
More informationLiver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties
Patient Education Treatment options This handout describes different kinds of tumors that form in the liver and how they are treated. About the Liver Your liver is the largest organ in your abdomen. It
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationPRECISE DIAGNOSIS AND TREATMENT OF NECK AND BACK PAIN
PRECISE DIAGNOSIS AND TREATMENT OF NECK AND BACK PAIN MEDICAL DIRECTOR Elgin, Itasca, Lake Barrington, McHenry, Libertyville, Huntley, Elmhurst John V. Prunskis M.D. FIPP JOHN V. PRUNSKIS Illinois M.D.
More informationStudy Objective and Design
Randomized, Open Label, Multicenter, Phase II Trial of Transcatheter Arterial Chemoembolization (TACE) Therapy in Combination with Sorafenib as Compared With TACE Alone in Patients with Hepatocellular
More informationOnline Supplementary Data. Country Number of centers Number of patients randomized
A Randomized, Double-Blind, -Controlled, Phase-2B Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients with Sepsis and Suspected Disseminated Intravascular
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 61000-61626, 61680-62264, 62268-62284, 62290-63048, 63055-64484, 64505-64595,
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationONCOLOGY LETTERS 5: , JUAN DU, XIAOPING QIAN and BAORUI LIU. Received July 15, 2012; Accepted October 9, DOI: /ol.2012.
ONCOLOGY LETTERS 5: 381-385, 2013 Long-term progression-free survival in a case of hepatocellular carcinoma with vertebral metastasis treated with a reduced dose of sorafenib: Case report and review of
More informationCase Studies of Laser Ablation for Liver Tumors
Case Studies of Laser Ablation for Liver Tumors Dr Giovan Giuseppe Di Costanzo, Head Physician, Department of Liver Pathophysiology - Cardarelli Hospital, Naples Case 1: HCC near vascular structures A
More informationBY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,
More informationRF Ablation: indication, technique and imaging follow-up
RF Ablation: indication, technique and imaging follow-up Trongtum Tongdee, M.D. Radiology Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand Objective Basic knowledge
More informationTRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD
UNIVERSITY OF PRETORIA STEVE BIKO ACADEMIC HOSPITAL SOUTH AFRICA TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD 1 INTRODUCTION Hepatic
More informationA) PUBLIC HEALTH B) PRESENTATION & DIAGNOSIS
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary), April 2017 by Dr. Jenny Ko (Medical Oncologist, Abbotsford Centre, BC Cancer
More informationSIRTEX Lunch Symposium, Cebu, 23 Nov Dr. Stephen L. Chan Department of Clinical Oncology The Chinese University of Hong Kong
SIRTEX Lunch Symposium, Cebu, 23 Nov 2013 Dr. Stephen L. Chan Department of Clinical Oncology The Chinese University of Hong Kong I will not talk on Mechanism of SIRT Data on efficacy of SIRT Epidemiology
More informationUTERINE FIBROID EMBOLIZATION
INTERVENTIONAL RADIOLOGY PROTOCOLS UTERINE FIBROID EMBOLIZATION Interventional Radiology Tower Health Medical Group offers the option to treat uterine fibroids with fibroid embolization (UFE), an alternative
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationHepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center
Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer
More informationRADIOFREQUENCY ABLATION
RADIOFREQUENCY ABLATION ELIZABETH DAVID M D FRCPC VASCULAR A ND INTERVENTIONAL RADIOLOGIST SUNNYBROOK HEALTH SCIENCES CENTRE GIST GASTROINTESTINAL STROMAL TUMORS Stromal or mesenchymal neoplasms affecting
More informationHepatobiliary and Pancreatic Malignancies
Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre
More informationInterventional Pain Management
Spinal Injections Can be beneficial for both chronic and acute pain depending on pathology Contraindications: Patient refusal Active infection Platelets less than 75 or inability to stop anticoagulation
More informationPROGRAMME AT A GLANCE
PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver
More informationRadiofrequency Ablation of Liver Tumors
Radiofrequency Ablation of Liver Tumors Michael M. Awad, Michael A. Choti Indications and Contraindications Indications Unresectable malignant tumors of the liver (e.g., hepatocellular carcinoma, colorectal
More informationLiver Disease. By: Michael Martins
Liver Disease By: Michael Martins Recently I have been getting a flurry of patients that have some serious liver complications. This week s literature review will be the dental management of the patients
More informationWHAT IS THE BEST APPROACH FOR TRANS-ARTERIAL THERAPY IN HCC?
WHAT IS THE BEST APPROACH FOR TRANS-ARTERIAL THERAPY IN HCC? Dr. Alexander Kim Chief, Vascular and Interventional Radiology, Medstar Georgetown University Hospital, USA DISCLAIMER Please note: The views
More informationChemosaturation: Indication, Technique and Outcome
Chemosaturation: Indication, Technique and Outcome Thomas J Vogl, S Koch, B Gebauer, W Willinek, C Engelke, R Bruening, F Wacker, A Enk I D I R: Institute of Diagnostic and Interventional Radiology Goethe
More informationAre we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?
Rajani Sharma, PGY1 Geriatrics CRC Project, 12/19/13 Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? A. Study Purpose and Rationale Hepatocellular carcinoma
More informationObjectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma
Imaging of Hepatocellular Carcinoma and the use of LI RADS Treatment of Hepatocellular Carcinoma Aaron D. Anderson, D.O. AOCR April 2015 Objectives Show how the use of LI RADS can simplify the diagnosis
More informationHEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:
HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,
More informationPERCUTANEOUS FACET JOINT DENERVATION
Status Active Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-95 Effective Date: 10/22/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationRADIATION SEGMENTECTOMY. Robert J Lewandowski, MD
RADIATION SEGMENTECTOMY Robert J Lewandowski, MD Robert Lewandowski, M.D. Consultant/Advisory Board: Cook Medical, LLC, Arsenal, BTG International, Boston Scientific Corp., ABK Reference Unlabeled/Unapproved
More information간암의조직검사 : 언제, 어떻게? 계명대학교의과대학내과학교실 정우진
간암의조직검사 : 언제, 어떻게? 계명대학교의과대학내과학교실 정우진 간생검한다 vs 안한다? M/81 Alcoholic LC, albumin 4.0, bil 0.6, Cr 1.06, glucose 141, afp 2.2, CA19-9 12.41 CT: R/O HCC in S8, R/O CC M/69 HBV(-), HCV(-), social alcoholics
More informationLiver Cancer (Hepatocellular Carcinoma or HCC) Overview
Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.
More informationMULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC
Dr Apoorva Gogna MBBS FRCR FAMS Consultant Interventional Radiology Center Department of Diagnostic Radiology SingaporeGeneral Hospital MULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC CASE HISTORY
More informationLiver Directed Therapy for Hepatocellular Carcinoma
Liver Directed Therapy for Hepatocellular Carcinoma Anil K Pillai MD, FRCR, Associate Professor, Department of Radiology UT Houston Health Science Center, Houston, TX, United States. Hepatocellular cancer
More informationEmbolotherapy for Cholangiocarcinoma: 2016 Update
Embolotherapy for Cholangiocarcinoma: 2016 Update Igor Lobko,MD Chief, Division Vascular and Interventional Radiology Long Island Jewish Medical Center GEST 2016 Igor Lobko, M.D. No relevant financial
More informationAPPROPRIATE USE GUIDELINES
APPROPRIATE USE GUIDELINES Appropriateness of Advanced Imaging Procedures (MRI, CT, Bone Scan/PET) in Patients with Neck Pain CDI QUALITY INSTITUTE: PROVIDER LED ENTITY (PLE) Updated June, 2017 Contents
More informationSWISS SOCIETY OF NEONATOLOGY. Multiple infantile hemangiomas in a preterm infant
SWISS SOCIETY OF NEONATOLOGY Multiple infantile hemangiomas in a preterm infant November 2017 Heschl K, Romaine Arlettaz R, Department of Neonatology (HK, AR), University Hospital Zurich, Switzerland Title
More informationInnovations in HCC Imaging: MDCT/MRI
Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic
More informationLiver Cancer. Su Jong Yu, M.D. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine
Liver Cancer Su Jong Yu, M.D. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine Primary Liver Cancer Hepatocellular carcinoma (HCC) : > 80% Derived
More informationTreatments for Common Pain Disorders. Matthew R. Kohler, MD Hudson Spine and Pain Medicine 03/01/2017
Treatments for Common Pain Disorders Matthew R. Kohler, MD Hudson Spine and Pain Medicine 03/01/2017 Acute Disc Herniation Conservative Approach (Four to Six Weeks) Physical Therapy, exercise and gentle
More informationTherapeutic Exercise And Manual Therapy For Persons With Lumbar Spinal Stenosis
Therapeutic Exercise And Manual Therapy For Persons With Lumbar Spinal Stenosis The program consisted of manual therapy twice per week (eg, soft tissue and neural The components of the Boot Camp Program
More informationLiver transplantation: Hepatocellular carcinoma
Liver transplantation: Hepatocellular carcinoma Alejandro Forner BCLC Group. Liver Unit. Hospital Clínic. University of Barcelona 18 de marzo 2015 3r Curso Práctico de Transplante de Órganos Sólidos Barcelona
More informationHepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC
Hepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC Objectives Identify patient risk factors for hepatocellular carcinoma (HCC) Describe strategies
More information6/16/2016. Treating Hepatocellular Carcinoma: Deciphering the Clinical Data. Liver Regeneration. Liver Regeneration
Treating : Deciphering the Clinical Data Derek DuBay, MD Associate Professor of Surgery Director of Liver Transplant Liver Transplant and Hepatobiliary Surgery UAB Department of Surgery Liver Regeneration
More informationMANAGEMENT OF OVERANTICOAGULATION AND PREOPERATIVE MANAGEMENT OF WARFARIN DOSE 1. GUIDELINES FOR THE MANAGEMENT OF AN ELEVATED INR
MANAGEMENT OF OVERANTICOAGULATION AND PREOPERATIVE MANAGEMENT OF WARFARIN DOSE 1. GUIDELINES FOR THE MANAGEMENT OF AN ELEVATED INR 1.1 Time to lower INR Prothrombinex-VF - 15 minutes Fresh Frozen Plasma
More informationManagement of Rare Liver Tumours
Gian Luca Grazi Hepato-Biliary-Pancreatic Surgery National Cancer Institute Regina Elena Rome Fibrolamellar Carcinoma Mixed Hepato Cholangiocellular Carcinoma Hepatoblastoma Carcinosarcoma Primary Hepatic
More informationLocoregional Therapy for Hepatoma
Locoregional Therapy for Hepatoma Robert D. Crane, MD Interventional Radiology Virginia Mason How do we know a liver mass is HCC? HCC : Bx Of pts getting liver transplant only ~ 5% had Bx to establish
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationThe Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page
The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page 2315-2321 Role of MRI in Assessment of Hepatocellular Carcinoma (HCC) after TACE (Trans-arterial Chemoembolization) with Persistent
More informationFacet syndrome in the cervical (upper) spine
Dr. Michael J Walls, MD 320 Thomas More Parkway. Ste 202 Crestview Hills, KY 41017 Phone: (859) 331-0956 Facet syndrome in the cervical (upper) spine Cervical facet syndrome, also known as cervical facet
More informationDisclosure. Speaker name: Prof. Maciej Pech I have the following potential conflicts of interest to report:
Disclosure Speaker name: Prof. Maciej Pech I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company
More informationHyperechoic renal masses
Hyperechoic renal masses Jean-Yves Meuwly, MD Department of Diagnostic and Interventional Radiology, University Hospital Lausanne, Switzerland Department of Diagnostic and Interventional Radiology Renal
More information2/2/14 INTRODUCTION. Vascular Anomalies: An Introduction to Classification and Coordination of Care. VASCULAR ANOMALIES: History and Classification
INTRODUCTION Vascular Anomalies: An Introduction to Classification and Coordination of Care Cindy Kerr,RN,MSN,CPNP Erin Spera,RN,MSN,CPNP Mary Beth Sylvia,RN,MS,FNP-BC 1in 3 newborns has a vascular birthmark
More informationPaul Martin MD FACG. University of Miami
Paul Martin MD FACG University of Miami 1 Liver cirrhosis of any cause Chronic C o c hepatitis epat t s B Risk increases with Male gender Age Diabetes Smoking ~5% increase in HCV-related HCC between 1991-28
More informationEVALUATION & LISTING. Your Child s Liver Transplant Evaluation. What is the Liver?
EVALUATION & LISTING Your Child s Liver Transplant Evaluation The University of Michigan is a national leader in liver transplantation, as well as the surgical and medical management of patients with liver
More informationPatient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for
High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...
More informationLiver and Pancreatic Case discussion
The Royal Marsden Liver and Pancreatic Case discussion Dr Ian Chau Consultant Medical Oncologist The Royal Marsden 77 year old gentleman with 2 months history of vague abdominal ache and clinically finding
More informationTreatment of the Medically Compromised Patient
Treatment of the Medically Compromised Patient Nashville Area Continuing Dental Education Series November 3, 2010 Harry J. Brown, MD Chief Medical Officer, Nashville Area Outline General Principles Specific
More information22110 vertebral segment; cervical vertebral segment; thoracic vertebral segment; lumbar
The following codes are authorized by Palladian Health for applicable product lines. Visit palladianhealth.com to request authorization and to access guidelines. Palladian Musculoskeletal Program Codes
More informationDamian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM
Damian Dupuy, MD Image Guided Intervention (IGI) Studies 10:25 11:05 AM Image Guided Intervention (IGI) Studies Damian E. Dupuy, M.D., FACR Professor of Diagnostic Imaging The Warren Alpert Medical School
More informationSolitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report
Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report Ellyda MN a and Mohd Shafie A b a Department of Radiology, International Islamic University Malaysia, Kuantan,
More informationMEDICAL POLICY. Proprietary Information of YourCare Health Plan
MEDICAL POLICY SUBJECT: INTERVERTEBRAL DISC DECOMPRESSION: PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
More informationWorkup of a Solid Liver Lesion
Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any
More informationSpinal Cord Ischemia Secondary to Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Published online: September 10, 2014 1662 0631/14/0083 0264$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC)
More informationRuolo della interventistica per le secondarietà epatiche e di altre sedi
Ruolo della interventistica per le secondarietà epatiche e di altre sedi Giancarlo Bizzarri Dipartimento di Diagnostica per Immagini e Radiologia Interventistica Ospedale Regina Apostolorum, Albano Laziale
More information9/10/2018. Liver Transplant for Hepatocellular Carcinoma (HCC): What is New? DISCLOSURES
UCSF Transplant 2018: Pioneering Advances in Transplantation DISCLOSURES Liver Transplant for Hepatocellular Carcinoma (HCC): What is New? I have no relevant commercial interests or relationships to report
More information